Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Expanded Access Program Using IMM-101 for Patients With Advanced Pancreatic Cancer

NCT04137822 is registered in ClinicalTrials.gov with Impatients N.V. trading as myTomorrows as lead sponsor.

NCT NCT04137822
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04137822 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Expanded Access Program Using IMM-101 for Patients With Advanced Pancreatic Cancer
Lead sponsor
Impatients N.V. trading as myTomorrows
Phase
Expanded access
Overall status
No longer available
Start date
Not reported
Completion date
Not reported
Enrollment
Not reported
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

pancreas cancer, pancreatic cancer, pancreatic cancer stage iii, pancreatic cancer stage iv